Joseph Abboud, MD
Orthopaedic Surgery · Philadelphia, PANPI 1588608731
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.7%), royalties or licence payments and education — rather than concentrated in one kind of arrangement. 36 manufacturers reported payments, led by Encore Medical, LP at 55.0% of the total. 2025 is the largest year on record at $1,313,543, 4.1 times the $319,265 reported in 2019. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,204 payments — averaging $3249.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Encore Medical, LP$2.2M
- Zimmer Biomet$1.3M
- Restor3d, Inc.$192K
- Stryker$131K
- Integra Lifesciences Corporation$59K
- Globus Medical$32K
- plus $65K from 30 others
Across 34 payments — averaging $3663.13 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Encore Medical, LP$45K
- Stryker$39K
- Arthrex$18K
- Zimmer Biomet$11K
- Lima USA, Inc.$8K
- Orthofix Medical, Inc.$2K
- plus $1K from 1 others
Across 3 payments — averaging $33,873 each. An ownership or investment interest held by the physician or an immediate family member.
- Restor3d, Inc.$102K
- Trice Medical, Inc.$0
What the payments were for
- Royalty or licence$1,652,47542%
- Consulting fees$1,945,55750%
- Speaking & faculty fees$3,0290%
- Travel & lodging$64,4132%
- Food & beverage$21,6291%
- Education$225,4816%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Encore Medical, LP | 499 | $2,152,593 |
| Zimmer Biomet | 428 | $1,281,620 |
| Restor3d, Inc. | 16 | $191,712 |
| Stryker | 87 | $130,537 |
| Integra Lifesciences Corporation | 9 | $59,232 |
| Globus Medical | 41 | $32,328 |
| Pacira Pharmaceuticals Incorporated | 14 | $22,987 |
| Insight Medical Systems, Inc. | 11 | $17,770 |
| Trice Medical, Inc. | 8 | $10,144 |
| Smith+Nephew | 8 | $3,592 |
| Osteocentric Technologies, Inc. | 6 | $2,250 |
| Pacira Therapeutics, Inc. | 3 | $1,545 |
| Synthes GmbH | 4 | $1,390 |
| Exactech, Inc. | 6 | $776 |
| Johnson & Johnson(2 entities) | 20 | $756 |
| Arthrex | 7 | $586 |
| Paladin Technology Solutions | 3 | $404 |
| Linvatec Corporation | 3 | $379 |
| Catalyst Orthoscience | 4 | $347 |
| Tenex Health Inc. | 3 | $315 |
| Biorez, Inc. | 1 | $240 |
| Lima USA, Inc. | 2 | $197 |
| Amarin Pharma, Inc. | 1 | $126 |
| Medacta USA, Inc. | 2 | $112 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Liberty Surgical Inc. | 2 | $94 |
| GSK | 3 | $73 |
| United Therapeutics Corporation | 3 | $73 |
| FX Shoulder Solutions, Inc | 1 | $68 |
| Electromed, Inc. | 1 | $52 |
| Medtronic | 1 | $50 |
| Vertex | 2 | $39 |
| Axogen | 1 | $30 |
| ZOLL Respicardia, Inc. | 1 | $25 |
| Abbott | 1 | $24 |
| Novartis | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DJO SURGICAL$2,825,548
- DJO Surgical AltiVate Anatomic System$584,296
- DJO Surgical AltiVate Reverse$80,649
- Juggerknotless Soft Anchor$64,152
- mymobility Platform$53,400
- INSPACE$52,614
- TSSM - TOTAL SHOULDER SYSTEM METAL$52,529
- Biowick$51,320
- Comprehensive Shoulder System$51,256
- ALLIANCE$49,744
- ICONIX$38,038
- BioWick X$34,812
- TAPESTRY$33,800
- Identity$20,200
- ARVIS$17,770
- Iovera$14,336
- Anthem$14,148
- DJO Surgical Turon Modular Shoulder System$14,000
- EXPAREL$13,234
- REUNION$10,588
How this compares
$3,912,584 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 37 | $133 |
| Tramadol Hcl | 13 | $43 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Philadelphia
- John FenlinPhiladelphia$5.9M
- Alexander VaccaroPhiladelphia$4.5M
- Samir MehtaPhiladelphia$3.6M
- Surena NamdariPhiladelphia$1.8M
- Neil ShethPhiladelphia$522K
- Amrit KhalsaPhiladelphia$475K
- Vahid EntezariPhiladelphia$393K
- Charles NelsonPhiladelphia$345K
- David GlaserPhiladelphia$176K
- Anthony NduPhiladelphia$173K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.